EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

The Triterpenoid MOMORDIN-Ic Inhibits HCMV by Preventing the Initiation of Gene Expression in Eukaryotic Cells

Eleanor Bradley, Emma Poole, Matthew B Reeves iD

Pathogens · 2024

DOI: 10.3390/pathogens13070546 ↗

At a glance

Journal article in Pathogens, 2024. Written by Eleanor Bradley and 2 co-authors. Institution: Institute of Immunity & Transplantation, Division of Infection & Immunity, UCL, Royal Free Campus, London NW3 2PP, UK. Major MEDLINE topics: Cytomegalovirus, Triterpenes, Antiviral Agents, RNA Polymerase II. 44 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust, MRC, Medical Research Council.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Human cytomegalovirus (HCMV) primary infection, re-infection, and reactivation from latency cause morbidity in immune-compromised patients. Consequently, potential therapeutic strategies remain of interest for the treatment of infection. Naturally occurring triterpenoids derived from plants have been demonstrated to have anti-viral activity, although their precise mechanisms of action are not always fully understood. Here, we investigate the activity of Mormordin Ic (Mc) and demonstrate that it is potently anti-viral against HCMV. Through investigation of the mechanistic basis of this anti-viral activity, we identify that it is inhibitory to both viral and host gene expression, and to highly induced genes in particular. We go on to observe that Mc impacts on RNA Pol II activity and, specifically, reduces the occupancy of elongating RNA Pol II at a viral promoter. Next, we demonstrate that Mc is inhibitory to HCMV reactivation, and in doing so identify that it has greater activity against the canonical major immediate early promoter compared to the alternative ip2 promoter located downstream. Finally, we see evidence of RNA Pol II occupancy at the ip2 promoter in undifferentiated myeloid cells. Thus, Mc is potently anti-viral and a potential tool to probe the activity of multiple promoters considered important for controlling HCMV reactivation.

Subjects

MeSH terms (MEDLINE)

CytomegalovirusTriterpenesAntiviral AgentsRNA Polymerase IIHumansCytomegalovirus InfectionsPromoter Regions, GeneticVirus ActivationCell LineGene Expression Regulation, Viral

Author keywords

anti-viralscytomegaloviruslatencytranscriptional regulation

Substances

TriterpenesAntiviral AgentsRNA Polymerase II

Authors and institutions

  • Institute of Immunity & Transplantation, Division of Infection & Immunity, UCL, Royal Free Campus, London NW3 2PP, UK.
  • Division of Virology, Department of Pathology, University of Cambridge, Addenbrooke's Campus, Cambridge CB2 0QQ, UK.

ORCID profiles: Matthew B Reeves

Funding

  • Wellcome Trust
  • MRC
  • Medical Research Council

Cite

APA

Bradley, E., Poole, E., & Reeves, M. B. (2024). The Triterpenoid MOMORDIN-Ic Inhibits HCMV by Preventing the Initiation of Gene Expression in Eukaryotic Cells. Pathogens. https://doi.org/10.3390/pathogens13070546

Vancouver

Bradley E, Poole E, Reeves MB. The Triterpenoid MOMORDIN-Ic Inhibits HCMV by Preventing the Initiation of Gene Expression in Eukaryotic Cells. Pathogens. 2024. doi:10.3390/pathogens13070546

BibTeX
@article{Bradley2024,
  author = {Bradley, Eleanor and Poole, Emma and Reeves, Matthew B},
  title = {The Triterpenoid MOMORDIN-Ic Inhibits HCMV by Preventing the Initiation of Gene Expression in Eukaryotic Cells},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13070546}
}
Start for free →